Utilization of Incontinence Procedures Following Prostate Cancer Treatment: A Population‐Level Analysis
Neurourology and Urodynamics · 2025
DOI: 10.1002/nau.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Ryan Davis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Urinary Sphincter, Artificial, Suburethral Slings. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Themen: Inkontinenz
Abstract (Originalsprache)
Introduction
Many experience incontinence following prostate cancer treatment. Patients suffering from stress incontinence may benefit from an artificial urinary sphincter (AUS) or urethral sling, however, rates of these procedures following radical prostatectomy (RP) and radiotherapy (RT) are not well‐defined. We aimed to assess rates of post‐RP and post‐RT utilization of AUS and urethral sling in a contemporary, national cohort from the large, federated database TriNetX.
Methods
We retrospectively assessed men ≥ 18 years old who were diagnosed with prostate cancer and eventually treated with RP or RT between 2005 and 2015 on TriNetX. Patients with any prior history of AUS or sling before prostate cancer treatment were excluded. Primary outcomes of interest were rates of AUS and sling utilization 6 months to 10 years after RP, RT, or both. We secondarily assessed rates of cystourethroscopy before incontinence procedure and patient factors associated with utilization of AUS or sling.
Results
Between 2005 and 2015, 13 392, 24 173, and 2353 prostate cancer patients were treated with RP, RT, or both treatments, respectively. After RP, within 6 months to 10 years, 244 patients (1.82%) underwent AUS implantation and 234 patients (1.75%) underwent sling placement, compared to 84 patients (0.35%) undergoing AUS implantation and 13 patients (0.05%) undergoing sling placement after RT. Of patients treated with both, 87 (3.70%) patients underwent AUS implantation and 26 (1.10%) underwent sling placement. One‐half to three‐fourths of these patients underwent cystourethroscopy before AUS/sling placement. RP, receiving care at an academic center, and being 45–69 years old compared to 70+ years old at prostate cancer treatment were significantly associated with AUS/sling utilization. Rates of utilization also varied across race/ethnicity.
Conclusions
AUS and urethral sling utilization amongst post‐RP and post‐RT prostate cancer survivors is low and variation in utilization exists based on patient characteristics. Our study emphasizes the importance of awareness of guidelines on incontinence after prostate treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Ryan Davis, Jeffrey C Loh-Doyle
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Davis, R., Ginsberg, D., & Loh-Doyle, J. C. (2025). Utilization of Incontinence Procedures Following Prostate Cancer Treatment: A Population‐Level Analysis. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70125
Vancouver
Davis R, Ginsberg D, Loh-Doyle JC. Utilization of Incontinence Procedures Following Prostate Cancer Treatment: A Population‐Level Analysis. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70125
BibTeX
@article{Davis2025,
author = {Davis, Ryan and Ginsberg, David and Loh-Doyle, Jeffrey C},
title = {Utilization of Incontinence Procedures Following Prostate Cancer Treatment: A Population‐Level Analysis},
journal = {Neurourology and Urodynamics},
year = {2025},
doi = {10.1002/nau.70125}
}
EUVIMED